These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 22552919)

  • 1. Bioinformatics and variability in drug response: a protein structural perspective.
    Lahti JL; Tang GW; Capriotti E; Liu T; Altman RB
    J R Soc Interface; 2012 Jul; 9(72):1409-37. PubMed ID: 22552919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of graph-based analysis of genomic sequence context for characterization of drug targets.
    Pancoska P
    Curr Drug Discov Technol; 2006 Sep; 3(3):175-88. PubMed ID: 17311563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of protein-chemical complex structures reveal new targets for established drugs.
    Kalinina OV; Wichmann O; Apic G; Russell RB
    PLoS Comput Biol; 2011 May; 7(5):e1002043. PubMed ID: 21573205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical-protein interactome and its application in off-target identification.
    Yang L; Wang KJ; Wang LS; Jegga AG; Qin SY; He G; Chen J; Xiao Y; He L
    Interdiscip Sci; 2011 Mar; 3(1):22-30. PubMed ID: 21369884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of structural biology in drug discovery.
    Tari LW
    Methods Mol Biol; 2012; 841():1-27. PubMed ID: 22222446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.
    Sheik Amamuddy O; Veldman W; Manyumwa C; Khairallah A; Agajanian S; Oluyemi O; Verkhivker G; Tastan Bishop O
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of germline and somatic missense variations on drug binding sites.
    Yan C; Pattabiraman N; Goecks J; Lam P; Nayak A; Pan Y; Torcivia-Rodriguez J; Voskanian A; Wan Q; Mazumder R
    Pharmacogenomics J; 2017 Mar; 17(2):128-136. PubMed ID: 26810135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization.
    Ezzat A; Zhao P; Wu M; Li XL; Kwoh CK
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(3):646-656. PubMed ID: 26890921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology analysis of protein-drug interactions.
    Colinge J; Rix U; Bennett KL; Superti-Furga G
    Proteomics Clin Appl; 2012 Jan; 6(1-2):102-16. PubMed ID: 22213655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cell in terms of structure and function: insights from structural genomics.
    Rigden DJ
    Curr Opin Biotechnol; 2006 Oct; 17(5):457-64. PubMed ID: 16890423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening and its integration with modern drug design technologies.
    Guido RV; Oliva G; Andricopulo AD
    Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning the drug target-likeness of a protein.
    Xu H; Xu H; Lin M; Wang W; Li Z; Huang J; Chen Y; Chen X
    Proteomics; 2007 Dec; 7(23):4255-63. PubMed ID: 17963289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old friends in new guise: repositioning of known drugs with structural bioinformatics.
    Haupt VJ; Schroeder M
    Brief Bioinform; 2011 Jul; 12(4):312-26. PubMed ID: 21441562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UniDrug-target: a computational tool to identify unique drug targets in pathogenic bacteria.
    Chanumolu SK; Rout C; Chauhan RS
    PLoS One; 2012; 7(3):e32833. PubMed ID: 22431985
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.